Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Despite the promising advances in novel cancer therapy such as immune checkpoint
inhibitors (ICIs), limitations including therapeutic resistance and toxicity remain. In recent …
inhibitors (ICIs), limitations including therapeutic resistance and toxicity remain. In recent …
The microbiome, cancer, and cancer therapy
BA Helmink, MAW Khan, A Hermann… - Nature medicine, 2019 - nature.com
With the advent of next-generation sequencing, we have an unprecedented ability to study
tumor and host genomes as well as those of the vast array of microorganisms that exist …
tumor and host genomes as well as those of the vast array of microorganisms that exist …
Pain-resolving immune mechanisms in neuropathic pain
Interactions between the immune and nervous systems are of central importance in
neuropathic pain, a common and debilitating form of chronic pain caused by a lesion or …
neuropathic pain, a common and debilitating form of chronic pain caused by a lesion or …
Fecal microbiota transplantation in neurological disorders
KEW Vendrik, RE Ooijevaar, PRC De Jong… - Frontiers in cellular …, 2020 - frontiersin.org
Background: Several studies suggested an important role of the gut microbiota in the
pathophysiology of neurological disorders, implying that alteration of the gut microbiota …
pathophysiology of neurological disorders, implying that alteration of the gut microbiota …
[HTML][HTML] Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy
D Chrysostomou, LA Roberts, JR Marchesi, JM Kinross - Gastroenterology, 2023 - Elsevier
Accumulating evidence supports not only the functional role of the gut microbiome in cancer
development and progression but also its role in defining the efficacy and toxicity of …
development and progression but also its role in defining the efficacy and toxicity of …
Modulating the microbiome to improve therapeutic response in cancer
JL McQuade, CR Daniel, BA Helmink… - The Lancet …, 2019 - thelancet.com
Although novel therapies, including immunotherapy, have dramatically improved outcomes
for many patients with cancer, overall outcomes are heterogeneous and existing biomarkers …
for many patients with cancer, overall outcomes are heterogeneous and existing biomarkers …
[HTML][HTML] Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential
The relationship between gut microbiota and neurological diseases, including chronic pain,
has received increasing attention. The gut microbiome is a crucial modulator of visceral …
has received increasing attention. The gut microbiome is a crucial modulator of visceral …
Metal drugs and the anticancer immune response
B Englinger, C Pirker, P Heffeter, A Terenzi… - Chemical …, 2018 - ACS Publications
The immune system deploys a multitude of innate and adaptive mechanisms not only to
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
C Panebianco, A Andriulli, V Pazienza - Microbiome, 2018 - Springer
Cancer is a major health burden worldwide, and despite continuous advances in medical
therapies, resistance to standard drugs and adverse effects still represent an important …
therapies, resistance to standard drugs and adverse effects still represent an important …
How do sensory neurons sense danger signals?
Sensory neurons are activated by physical and chemical stimuli, eliciting sensations such as
temperature, touch, pain, and itch. From an evolutionary perspective, sensing danger is …
temperature, touch, pain, and itch. From an evolutionary perspective, sensing danger is …